Sign in
8-K

Current Report

IOVANCE BIOTHERAPEUTICS, INC. Filed Acc 0001144204-16-121003

Material agreement · Executive or director change

  • Item 1.01 Entry into a material definitive agreement
  • Item 5.02 Departure or appointment of directors or officers

From the SEC's structured data for this filing

Loading v447597_8k.htm…